Clinical Trial Update: NFIL3-induced Pathological Enhancement of IgE Class Switch Recombination in Hyper-IgE Syndrome

View source ↗

Summary

Clinical trial update examining NFIL3-induced enhancement of IgE class switch recombination in Hyper-IgE syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyper-ige Syndrome

Snippet

Sponsor: Shanghai Children's Medical Center | Conditions: Job Syndrome | Status: UNKNOWN